Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3240 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.81 USD | +0.63% | +11.09% | +34.36% | +278.74% | 342.41 M USD | ||
| 3250 |  OABI OmniAb, Inc. - Common Stock | 2.34 USD | +0.86% | -3.70% | +1.30% | +11.96% | 339.24 M USD | ||
| 3251 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.91 USD | -3.64% | -2.02% | +50.78% | +162.16% | 339.19 M USD | ||
| 3262 |  IRD Opus Genetics, Inc. - Common Stock | 4.08 USD | +0.74% | -1.45% | +0.49% | +9.68% | 332.09 M USD | ||
| 3272 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.32 USD | 0.00% | +0.76% | +9.09% | -23.26% | 329.07 M USD | ||
| 3305 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.35 USD | -0.42% | +13.53% | +48.73% | +422.22% | 316.22 M USD | ||
| 3329 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.99 USD | +1.53% | +1.27% | +10.22% | +15.32% | 307.98 M USD | ||
| 3330 |  HELP Cybin Inc. - Common Stock | 5.96 USD | -1.16% | -7.31% | +47.16% | -33.56% | 307.73 M USD | ||
| 3343 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.65 USD | -4.62% | +2.48% | 0.00% | +83.33% | 305.72 M USD | ||
| 3351 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | -0.22% | +5.02% | +90.08% | +113.95% | 302.94 M USD | ||
| 3370 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.88 USD | -0.51% | +1.84% | +14.12% | +57.72% | 296.68 M USD | ||
| 3381 |  MGNX MacroGenics, Inc. - Common Stock | 4.63 USD | -2.53% | +1.31% | +18.11% | +210.74% | 294.30 M USD | ||
| 3387 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.96 USD | -0.90% | -1.87% | +42.08% | +8.73% | 292.64 M USD | ||
| 3388 |  FBRX Forte Biosciences, Inc. - Common Stock | 21.07 USD | -5.30% | -0.14% | +33.44% | -28.21% | 292.57 M USD | ||
| 3392 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.49 USD | +0.54% | +0.54% | +17.21% | +7.46% | 290.77 M USD | ||
| 3423 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.30 USD | -4.22% | +33.05% | +82.35% | -7.00% | 277.03 M USD | ||
| 3432 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.42 USD | -9.36% | -17.97% | -9.02% | +27.37% | 274.05 M USD | ||
| 3438 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.41 USD | -1.16% | +2.71% | +1.19% | -31.53% | 271.59 M USD | ||
| 3442 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.02 USD | -1.46% | +2.02% | +22.42% | -0.98% | 266.71 M USD | ||
| 3443 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.16 USD | -2.21% | -21.42% | -18.53% | +79.98% | 266.56 M USD |
Notizie Biotechnology Stocks
TD Cowen conferma il Buy su Prime Medicine dopo la vittoria nell’arbitrato
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |